We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$540M
AUM Growth
-$17.9M
Cap. Flow
-$41M
Cap. Flow %
-7.6%
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$21.8M
2
STLA icon
Stellantis
STLA
+$20.9M
3
EPHE icon
iShares MSCI Philippines ETF
EPHE
+$11.4M
4
RACE icon
Ferrari
RACE
+$10.4M
5
DB icon
Deutsche Bank
DB
+$9.96M

Sector Composition

Rank Sector Weight
1 Financials 13.08%
2 Consumer Discretionary 12.84%
3 Technology 8.88%
4 Materials 7.83%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
276
Republic Services
RSG
$66.9B
$136K 0.03%
1,467
-828
-36% -$72.4K
TVRD
277
Tvardi Therapeutics
TVRD
$23.6M
$136K 0.03%
224
-276
-55% -$194K
ESTC icon
278
Elastic
ESTC
$6.44B
$135K 0.03%
+1,894
New +$139K
MAT icon
279
Mattel
MAT
$4.29B
$135K 0.03%
+9,657
New +$115K
ALXN
280
DELISTED
Alexion Pharmaceuticals
ALXN
$135K 0.03%
1,199
-1,003
-46% -$107K
HYG icon
281
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$133K 0.02%
1,500
IAG icon
282
IAMGOLD
IAG
$8.44B
$132K 0.02%
+39,228
New +$139K
AGNC icon
283
AGNC Investment
AGNC
$12.4B
$132K 0.02%
7,252
-2,087
-22% -$35.5K
MLM icon
284
Martin Marietta Materials
MLM
$34.3B
$126K 0.02%
481
-1,360
-74% -$363K
HLT icon
285
Hilton Worldwide
HLT
$74.9B
$124K 0.02%
1,133
ADI icon
286
Analog Devices
ADI
$180B
$123K 0.02%
1,049
-8,417
-89% -$949K
CWB icon
287
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.56B
$120K 0.02%
2,096
-180
-8% -$9.69K
CRON
288
Cronos Group
CRON
$1.06B
$120K 0.02%
14,325
-25,210
-64% -$193K
CVX icon
289
Chevron
CVX
$381B
$119K 0.02%
+1,023
New +$120K
XLNX
290
DELISTED
Xilinx Inc
XLNX
$118K 0.02%
1,196
-103
-8% -$9.68K
ENS icon
291
EnerSys
ENS
$6.86B
$118K 0.02%
1,585
FLOT icon
292
iShares Floating Rate Bond ETF
FLOT
$10.2B
$118K 0.02%
2,311
-236
-9% -$12K
TSM icon
293
TSMC
TSM
$2.05T
$118K 0.02%
+2,016
New +$107K
SSRM icon
294
SSR Mining
SSRM
$5.46B
$116K 0.02%
6,848
+2,810
+70% +$43.8K
LRCX icon
295
Lam Research
LRCX
$360B
$115K 0.02%
3,860
-2,280
-37% -$60.5K
VWOB icon
296
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
$115K 0.02%
1,401
-120
-8% -$9.64K
LQD icon
297
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
$113K 0.02%
1,820
+300
+20% +$38.2K
ETN icon
298
Eaton
ETN
$153B
$112K 0.02%
1,198
-336
-22% -$29.8K
HIG icon
299
Hartford Financial Services
HIG
$38.5B
$111K 0.02%
1,870
+153
+9% +$9.18K
SID icon
300
Companhia Siderúrgica Nacional
SID
$1.49B
$109K 0.02%
31,367
+30,813
+5,562% +$95.9K

Similar funds

Exane Derivatives's Q4 2019 Portfolio in Review

As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Exane Derivatives opened a new position in IBM worth $9M.

  • Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
  • Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
  • Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
  • Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
  • Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
  • Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
  • Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.